Elizabeth Wiley

478 total citations
20 papers, 317 citations indexed

About

Elizabeth Wiley is a scholar working on Genetics, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Elizabeth Wiley has authored 20 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 6 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Elizabeth Wiley's work include Chronic Lymphocytic Leukemia Research (6 papers), Advanced Breast Cancer Therapies (4 papers) and Genetic factors in colorectal cancer (3 papers). Elizabeth Wiley is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Advanced Breast Cancer Therapies (4 papers) and Genetic factors in colorectal cancer (3 papers). Elizabeth Wiley collaborates with scholars based in United States, Netherlands and Puerto Rico. Elizabeth Wiley's co-authors include Malia F. Mason, Daniel R. Ames, Alice J. Lee, Jennifer E. Axilbund, John C. Byrd, Jennifer A. Woyach, Jesús G. Berdeja, Ian W. Flinn, Gerard Lozanski and Farrukh T. Awan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Elizabeth Wiley

20 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Wiley United States 11 100 99 66 46 43 20 317
Jacob Dijkstra Netherlands 12 17 0.2× 124 1.3× 54 0.8× 104 2.3× 15 0.3× 50 485
Jennifer C. King United States 14 255 2.5× 40 0.4× 45 0.7× 45 1.0× 25 0.6× 49 694
Molly Bruce Patterson United States 8 60 0.6× 134 1.4× 28 0.4× 155 3.4× 19 0.4× 16 515
Irene Tan United States 10 20 0.2× 14 0.1× 14 0.2× 63 1.4× 15 0.3× 32 537
Sarah Kolla United States 9 119 1.2× 45 0.5× 12 0.2× 30 0.7× 23 0.5× 16 537
Annika Lindskog Sweden 11 24 0.2× 25 0.3× 11 0.2× 162 3.5× 156 3.6× 27 545
Morgan S. Wilson United States 10 138 1.4× 231 2.3× 88 1.3× 253 5.5× 45 1.0× 21 746
Miguel Morey Spain 7 75 0.8× 96 1.0× 66 1.0× 90 2.0× 14 0.3× 23 395
Pamela A. Smith United States 13 100 1.0× 21 0.2× 13 0.2× 53 1.2× 44 1.0× 36 535
Keith Holmes United Kingdom 16 126 1.3× 10 0.1× 110 1.7× 61 1.3× 28 0.7× 26 1.5k

Countries citing papers authored by Elizabeth Wiley

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Wiley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Wiley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Wiley more than expected).

Fields of papers citing papers by Elizabeth Wiley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Wiley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Wiley. The network helps show where Elizabeth Wiley may publish in the future.

Co-authorship network of co-authors of Elizabeth Wiley

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Wiley. A scholar is included among the top collaborators of Elizabeth Wiley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Wiley. Elizabeth Wiley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leal, Ticiana, Marina N. Sharifi, Nancy Chan, et al.. (2022). A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782). Cancer Medicine. 11(21). 3969–3981. 9 indexed citations
2.
Beaudreau, Sherry A., Marcela C. Otero, Jessica A. Walker, et al.. (2021). Problem Solving Training for Veterans with Complex Comorbidities: Treatment Delivery Adaptations during COVID-19. Clinical Gerontologist. 45(1). 145–158. 4 indexed citations
3.
Duvivier, Robbert, Elizabeth Wiley, & John R. Boulet. (2019). Supply, distribution and characteristics of international medical graduates in family medicine in the United States: a cross-sectional study. BMC Family Practice. 20(1). 47–47. 10 indexed citations
4.
Mason, Malia F., Elizabeth Wiley, & Daniel R. Ames. (2018). From belief to deceit: How expectancies about others' ethics shape deception in negotiations. Journal of Experimental Social Psychology. 76. 239–248. 9 indexed citations
5.
Edelstein, Daniel L., Marcia Cruz–Correa, Marievelisse Soto‐Salgado, et al.. (2015). Risk of Colorectal and Other Cancers in Patients With Serrated Polyposis. Clinical Gastroenterology and Hepatology. 13(9). 1697–1699. 19 indexed citations
6.
Tieu, Alan H., Daniel L. Edelstein, Jennifer E. Axilbund, et al.. (2015). Clinical Characteristics of Multiple Colorectal Adenoma Patients Without Germline APC or MYH Mutations. Journal of Clinical Gastroenterology. 50(7). 584–588. 15 indexed citations
7.
Wiley, Elizabeth, et al.. (2015). Health and Asylum Seekers in Europe. bonndoc (University of Bonn). 1 indexed citations
8.
Woyach, Jennifer A., Farrukh T. Awan, Ian W. Flinn, et al.. (2014). A phase 1 trial of the Fc-engineered CD19 antibody XmAb5574 (MOR00208) demonstrates safety and preliminary efficacy in relapsed CLL. Blood. 124(24). 3553–3560. 51 indexed citations
9.
10.
Mason, Malia F., Alice J. Lee, Elizabeth Wiley, & Daniel R. Ames. (2013). Precise offers are potent anchors: Conciliatory counteroffers and attributions of knowledge in negotiations. Journal of Experimental Social Psychology. 49(4). 759–763. 82 indexed citations
11.
Flynn, Joseph M., Leslie A. Andritsos, Jeffrey A. Jones, et al.. (2013). Dinaciclib (SCH 727965) Is a Novel Cyclin-Dependent Kinase (CDK) Inhibitor That Exhibits Activity In Patients With Relapsed Or Refractory Chronic Lymphocytic Leukemia (CLL). Blood. 122(21). 871–871. 15 indexed citations
12.
Huntoon, Kristin, et al.. (2012). Self-reported evaluation of competencies and attitudes by physicians-in-training before and after a single day legislative advocacy experience. BMC Medical Education. 12(1). 47–47. 12 indexed citations
13.
Axilbund, Jennifer E. & Elizabeth Wiley. (2012). Genetic Testing by Cancer Site. The Cancer Journal. 18(4). 350–354. 14 indexed citations
14.
Huntoon, Kristin, Christopher A. Scannell, Elizabeth Wiley, et al.. (2011). Healthcare Reform and the Next Generation: United States Medical Student Attitudes toward the Patient Protection and Affordable Care Act. PLoS ONE. 6(9). e23557–e23557. 23 indexed citations
15.
Brockman, John A., et al.. (2011). The “I Want to Help People” Dilemma: How Advocacy Training Can Improve Health. Academic Medicine. 86(11). 1349–1349. 10 indexed citations
16.
Flynn, Joseph M., Justin A. Jones, Leslie A. Andritsos, et al.. (2011). Phase I study of the CDK inhibitor dinaciclib (SCH 727965) in patients (pts) with relapsed/refractory CLL.. Journal of Clinical Oncology. 29(15_suppl). 6623–6623. 10 indexed citations
17.
Yang, Y. Tony, et al.. (2011). Individualized medicine and pharmacogenomics: ethical, legal and policy challenges. 9(2). 48–57. 1 indexed citations
18.
19.
Flynn, Joseph M., Amy J. Johnson, Leslie A. Andritsos, et al.. (2009). The Cyclin Dependent Kinase Inhibitor SCH 727965 Demonstrates Promising Pre-Clinical and Early Clinical Activity in Chronic Lymphocytic Leukemia.. Blood. 114(22). 886–886. 6 indexed citations
20.
James, Mary, Elizabeth Wiley, & Brant E. Fries. (2007). Predicting Nursing Facility Transition Candidates Using AID: A Case Study. The Gerontologist. 47(5). 625–632. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacob Dijkstra Breakdown of academic impact, for papers by Jennifer C. King Breakdown of academic impact, for papers by Molly Bruce Patterson Breakdown of academic impact, for papers by Irene Tan Breakdown of academic impact, for papers by Sarah Kolla Breakdown of academic impact, for papers by Annika Lindskog Breakdown of academic impact, for papers by Morgan S. Wilson Breakdown of academic impact, for papers by Miguel Morey Breakdown of academic impact, for papers by Pamela A. Smith Breakdown of academic impact, for papers by Keith Holmes
Rankless by CCL
2026